Next, to identify the most representative marker of TAMs in glioma, univariate and multivariate analyses were performed to evaluate the effects of these markers (data not shown), revealing CD204 as the only independent prognosticator in glioma patients in both datasets (Table 1). This evidence concerns the gene MSR1 and glioma.